Thrombosis and Haemostasis has a long history of working with our partners in producing and distributing their content, such as symposium or congress proceedings, to a larger and more targeted audience. This content is distributed alongside our standard journal content as a loose insert, or it is printed directly within the journal itself.

If you are interested in producing your special content with the journal of Thrombosis and Haemostasis, you can find out more information here, or by contacting Laura Lenz at Laura.Lenz(at)schattauer.de.

Available Content:

• Supplement 1/2011 - European Platelet Academy: Contemporary issues in atherothrombosis
  This supplement was supported by an unrestricted grant to the University of Sheffield, UK, from Eli Lilly and Daiichi Sankyo in support of the European Platelet Academy.
  Published alongside the regular June 2011 issue of Thrombosis and Haemostasis
  View Issue


• CSL Behring – Prof. Heimburger Award 2011 celebrates the work of talented young investigators
  News from the CSL Behring – Prof. Heimburger Award 2011 Symposium in Marburg, Germany, on April 8, 2011.
  Sponsored by CSL Behring GmbH, Marburg, Germany.
  Printed in the August 2011 issue of Thrombosis and Haemostasis.
  Download


• CSL Behring – Challenges and innovations in the treatment of bleeding disorders.
  News from the Hemophilia 2010 World Congress in Buenos Aires, Argentina. Text is based upon CSL Behring symposium which occurred on July 13th, 2010.
  Sponsored by CSL Behring, Marburg, Germany.
  Printed in the November 2010 issue of Thrombosis and Haemostasis.
  Download


• CSL Behring – Prof. Heimburger Award 2010 rewards excellence in coagulation research.
  News from the CSL Behring – Prof. Heimburger Award 2010 Symposium in Marburg, Germany, on March 29, 2010.
  Sponsored by CSL Behring GmBH, Marburg, Germany.
  Printed in the September 2010 issue of Thrombosis and Haemostasis.
  Download


• New perspectives, new strategies in venous thromboembolic disease
  A satellite symposium at the 50th ASH Annual Meeting: December 5, 2008 in San Francisco, California, USA.
  Sponsored by an educational grant from Bayer Healthcare AG and Ortho-McNeil Inc., Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. Administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
  Distributed in association with the June issue of Thrombosis and Haemostasis.
  Download
  

Past Content:

2011

• CSL Behring – Prof. Heimburger Award 2011 celebrates the work of talented young investigators
  News from the CSL Behring – Prof. Heimburger Award 2011 Symposium in Marburg, Germany, on April 8, 2011.
  Sponsored by CSL Behring GmbH, Marburg, Germany.
  Printed in the August 2011 issue of Thrombosis and Haemostasis.
  Download


• VWF monotherapy in von Willebrand disease – Reliabe hemostasis
  A special symposium on new therapeutic possibilities in hemophilia and von Willebrand syndrome at the 55th Annual Meeting of the GTH; February 16, 2011 in Wiesbaden, Germany.
  Sponsored by SOBI (Swedish Orphan Biovitrum).
  Distributed with the July 2011 issue of Thrombosis and Haemostasis.


• Supplement 1/2011 - European Platelet Academy: Contemporary issues in atherothrombosis
  This supplement was supported by an unrestricted grant to the University of Sheffield, UK, from Eli Lilly and Daiichi Sankyo in support of the European Platelet Academy.
  Published alongside the regular June 2011 issue of Thrombosis and Haemostasis
  View Issue


• Inhibitors in haemophilia A – Prevention, current management and personalised therapy perspectives.
  Text is based on an Octapharma Symposium which occurred on July 13th, 2010, at the World Federation of Haemophilia Congress in Buenos Aires, Argentina.
  This loose insert was sponsored by Octapharma AG (Lachen, Switzerland).
  Distributed in association with the March 2011 issue of Thrombosis and Haemostasis


• Shifting for a new paradigm in the management of von Willebrand patients.
  Text is from an LFB satellite symposium which occurred on July 12, 2010 at the World Federation of Hemophilia Congress in Argentina.
  Sponsored by LFB.
  Distributed with the January 2011 issue of Thrombosis and Haemostasis. 
  

2010

• CSL Behring – Challenges and innovations in the treatment of bleeding disorders.
  News from the Hemophilia 2010 World Congress in Buenos Aires, Argentina. Text is based upon CSL Behring symposium which occurred on July 13th, 2010.
  Sponsored by CSL Behring, Marburg, Germany.
  Printed in the November 2010 issue of Thrombosis and Haemostasis.


• CSL Behring – Prof. Heimburger Award 2010 rewards excellence in coagulation research.
  News from the CSL Behring – Prof. Heimburger Award 2010 Symposium in Marburg, Germany, on March 29, 2010.
  Sponsored by CSL Behring GmBH, Marburg, Germany.
  Printed in the September 2010 issue of Thrombosis and Haemostasis.
  
  
• Von Willibrand disease – VWF monotherapy. Why not focus on the missing ingredient?
  A special symposium presented at the GTH 2010 congress in Nürnberg, Germany on February 26, 2010 (“WILLFACT® - purely designed to protect patients with von Willebrand disease”).
  Sponsored by LFB SA, Courtaboeuf Cedex, France.
  Distributed in association with the June 2010 issue of Thrombosis and Haemostasis.

• From human to humans – Introducing the first recombinant human FVIII product produced from a human cell line
  A special symposium at the International Society on Thrombosis and Haemostasis (ISTH) Congress 2009: July 15, 2009, in Boston, Massachusetts, USA.
  Sponsored by Octapharma AG, Lachen, Switzerland.
  Distributed with the February issue of Thrombosis and Haemostasis.

2009

• Prevention and eradication of FVIII inhibitors: Bridging lab and field research
  A special symposium at the International Society on Thrombosis and Haemostasis (ISTH) Congress 2009: July 12, 2009 in Boston Massachusetts, USA.
  Sponsored by Octapharma AG, Lachen, Switzerland.
  Distributed in association with the December issue of Thrombosis and Haemostasis.

• Addressing challenges in the care of hemophilia patients with inhibitors
  A symposium at the World Federation of Hemophilia's XXVIII International Congress: June 1-5, 2008 in Istanbul, Turkey.
  Sponsored by Baxter Healthcare, USA.
  Distributed in association with the November issue of Thrombosis and Haemostasis.

• News from the XXII Congress of the ISTH in Boston, USA. Treatment of congenital bleeding disorders: Future trends in Management
  CSL Behring Symposium “Treatment of congenital bleeding disorders: future trends in management”, July 15, 20009 in Boston, USA.
  Printed in November issue of Thrombosis and Haemostasis.

• News from the XXII Congress of the ISTH in Boston, USA: Diagnosis and management of inherited von Willibrand disease in the next decade: a clinical perspective
  CSL Behring Symposium “Diagnosis and management of inherited von Willibrand disease in the next decade: a clinical perspective”, July 13, 2009 in Boston, USA.
  Printed in October issue of Thrombosis and Haemostasis.

• CSL Behring Announces Winners of the 2009 Prof. Heimburger Award.
  CSL Behring, Prof. Heimburger Award symposium, May 29, 2009, Marburg, Germany.
  Printed in the September issue of Thrombosis and Haemostasis.

• 2009 Prof. Heimburger Award Symposium in Marburg, Germany
  Prof. Heimburger Award honours the next generation of haemophilia treatment specialists
  CSL Behring, Prof. Heimburger Award symposium, May 29, 2009, Marburg, Germany.
  Printed in the September issue of Thrombosis and Haemostasis.

• New perspectives, new strategies in venous thromboembolic disease
  A satellite symposium at the 50th ASH Annual Meeting: December 5, 2008 in San Francisco, California, USA.
  Sponsored by an educational grant from Bayer Healthcare AG and Ortho-McNeil Inc., Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. Administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
  Distributed in association with the June issue of Thrombosis and Haemostasis.
  Download

• Looking for milestone improvements in VWD treatment - tasks defined and resolved
  A symposium at the Hemophilia 2008 World Congress: June 3, 2008 in Istanbul, Turkey.
  Sponsored by Octapharma AG, Switzerland.
  Distributed in association with the March issue of Thrombosis and Haemostasis.

2008

• The future management of thromboembolic disorders
  Special symposium held during the 54th Annual Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis: July 2, 2008 in Vienna, Austria.
  Sponsored by Boehringer Ingelheim.
  Distributed in association with the December issue of Thrombosis and Haemostasis.

• Symposium: “Von Willibrand disease – a FVIII deficiency? – Selective approach with a dedicated VWF product almost devoid of FVIII”
  A symposium at the XXVIIIth  Hemophilia World Congress, WFH 2008: June 2, 2008 in Istanbul, Turkey.
  Sponsored by LFB.
  Distributedin association with the November issue of Thrombosis and Haemostasis.

• Von Willebrand factor in factor VIII complex concentrates: From laboratory to clinical practice
  A symposium at the XXVIIIth  Hemophilia World Congress, WFH 2008: June 2, 2008 in Istanbul, Turkey.
  Sponsored by Octapharma AG, Switzerland.
  Distributed in association with the October  issue of Thrombosis and Haemostasis.

2007

• Haemophilia patients with inhibitors – single-dose management with rFVIIa: Minimizing the need for repeated dosing.
  A symposium at the XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH): July 11, 2007 in Geneva, Switzerland.
  Sponsored by Novo Nordisk, Switzerland.
  Distributed in association with the December issue of Thrombosis and Haemostasis.

• Haemophilia – VWF in preventing FVIII inhibitors. When science meets clinical experience.
  A symposium at the XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH): July 11, 2007 in Geneva, Switzerland.
  Sponsored by Octapharma AG, Switzerland.
  Distributed in association with the December issue of Thrombosis and Haemostasis.

2006

• Educational symposium: “FVIII-neutralizing antibodies – Todays major safety concern for patients with hemophilia A”
  A symposium at the Hemophilia World Congress, WFH 2006: May 24, 2006 in Vancouver, British Columbia, Canada.’
  Sponsored by Octapharma AG, Switzerland.
  Distributed in association with the September issue of Thrombosis and Haemostasis.